Literature DB >> 21953022

Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II).

Francesco Patti1, Maria Pia Amato, Maria Trojano, Stefano Bastianello, Maria Rosalia Tola, Orietta Picconi, Sabina Cilia, Salvatore Cottone, Luigi M E Grimaldi.   

Abstract

PURPOSE: To report longitudinal changes in and explore the influence of cognition on social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis (RRMS).
METHODS: Italian patients (18-50 years) with RRMS and Expanded Disability Status Scale (EDSS) score ≤4.0 were assigned to interferon β-1a, 44 or 22 μg subcutaneously three times weekly, and underwent annual assessments for social functioning (Environmental Status Scale [ESS]) over 3 years.
RESULTS: Baseline total ESS score did not differ between patients with and without cognitive impairment (P = 0.505). Total ESS score remained low (<2.0) and stable over 3 years in the whole study population, but worsened slightly when assessed by assigned treatment or treatment and baseline cognitive status (both P = 0.004), driven mostly by changes in the 'transportation' and 'financial/economic status' subscales. The strongest independent predictor of worsening ESS score was baseline EDSS score. Test-retest analyses confirmed that total ESS score and most subscales changed little over 3 years.
CONCLUSION: ESS scores remained low and changed minimally over 3 years, reflecting the mild physical disability and good cognitive performance in this patient population. Determining the influence of cognitive function and treatment on longitudinal changes in social functioning requires further studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21953022     DOI: 10.1007/s11136-011-0021-6

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  39 in total

1.  Psychosocial issue in children and adolescents with multiple sclerosis.

Authors:  B Goretti; A Ghezzi; E Portaccio; S Lori; V Zipoli; L Razzolini; L Moiola; M Falautano; M F De Caro; R Viterbo; F Patti; R Vecchio; C Pozzilli; V Bianchi; M Roscio; G Comi; M Trojano; M P Amato
Journal:  Neurol Sci       Date:  2010-05-08       Impact factor: 3.307

2.  A normative study on visual reaction times and two Stroop colour-word tests.

Authors:  R Barbarotto; M Laiacona; R Frosio; M Vecchio; A Farinato; E Capitani
Journal:  Ital J Neurol Sci       Date:  1998-06

3.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

4.  The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population.

Authors:  M P Amato; E Portaccio; B Goretti; V Zipoli; L Ricchiuti; M F De Caro; F Patti; R Vecchio; S Sorbi; M Trojano
Journal:  Mult Scler       Date:  2006-12       Impact factor: 6.312

Review 5.  Measuring handicap in multiple sclerosis.

Authors:  A J Thompson
Journal:  Mult Scler       Date:  1999-08       Impact factor: 6.312

6.  A health-related quality of life measure for multiple sclerosis.

Authors:  B G Vickrey; R D Hays; R Harooni; L W Myers; G W Ellison
Journal:  Qual Life Res       Date:  1995-06       Impact factor: 4.147

7.  Redefining functionality and treatment efficacy in multiple sclerosis.

Authors:  John F Foley; David W Brandes
Journal:  Neurology       Date:  2009-06-09       Impact factor: 9.910

8.  Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis.

Authors:  F Patti; C Pozzilli; E Montanari; A Pappalardo; L Piazza; A Levi; E Onesti; I Pesci
Journal:  Mult Scler       Date:  2007-02-16       Impact factor: 6.312

9.  Evaluation of disability, incapacity and environmental status scales in multiple sclerosis.

Authors:  T Fog; A Heltberg; K Kyhn; E Mellerup; N E Raun; I Zeeberg
Journal:  Acta Neurol Scand Suppl       Date:  1984

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  1 in total

1.  Managing Neuropsychological Impairment in Multiple Sclerosis: Pilot Study on a Standardized Metacognitive Intervention.

Authors:  Jana Pöttgen; Stephanie Lau; Iris Penner; Christoph Heesen; Steffen Moritz
Journal:  Int J MS Care       Date:  2015 May-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.